A new analysis in Clinical Gastroenterology and Hepatology (Brenner et al., Sept 2025) examines geodemographic trends in private equity (PE) acquisitions of U.S. gastroenterology practices from 2013–2023. The study confirms that GI has become a prime target for PE investment, driven by its high-volume procedures, strong ancillary revenue streams, and outpatient consolidation opportunities. What was once an abstract trend is now local and visible, directly shaping daily GI practice across the country. The findings underscore how PE is reshaping practice ownership and care delivery in gastroenterology.
Trending
- Strategic AI Mastery: The decision that changed everything — and could change GI forever sent
- GI pay by years of experience (Becker’s GI & Endoscopy)
- The providers hit hardest by the government shutdown (Advisory Board)
- It’s Not the Polyp, It’s the Provider: Study (Conexiant )
- Rideshare ‘potentially scalable intervention’ to improve colonoscopy after abnormal FIT (Healio)
- A Promising, Noninvasive Screening Tool for Colorectal Polyps (DocWire News)
- Geodemographic Trends in Private Equity Acquisitions of U.S. Gastroenterology Practices: An Analysis of Transactions From 2013 to 2023 (Clinical Gastroenterology and Hepatology)
- How AI Is Redefining Healthcare’s Front Door (Forbes)
